000 06235nam a22003855i 4500
001 280251
003 MX-SnUAN
005 20160429154016.0
007 cr nn 008mamaa
008 150903s2007 xxu| o |||| 0|eng d
020 _a9780387720050
_99780387720050
024 7 _a10.1007/9780387720050
_2doi
035 _avtls000332218
039 9 _a201509030757
_bVLOAD
_c201404122053
_dVLOAD
_c201404091823
_dVLOAD
_y201402041023
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aQR180-189.5
100 1 _aShurin, Michael R.
_eeditor.
_9305070
245 1 0 _aImmune-Mediated Diseases :
_bFrom Theory to Therapy /
_cedited by Michael R. Shurin, Yuri S. Smolkin.
264 1 _aNew York, NY :
_bSpringer New York,
_c2007.
300 _axxI, 458 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aAdvances in Experimental Medicine and Biology,
_x0065-2598 ;
_v601
500 _aSpringer eBooks
505 0 _aImmune-Mediated Diseases -- Immune-Mediated Diseases: Where Do We Stand? -- Immunodeficiencies: News and Updates -- The Four Most Common Pediatric Immunodeficiencies -- Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Inheritance: Model for Autoaggression -- DiGeorge Syndrome/Velocardiofacial Syndrome: The Chromosome 22q11.2 Deletion Syndrome -- Leukocyte Adhesion Deficiencies: Molecular Basis, Clinical Findings, and Therapeutic Options -- Nijmegen Breakage Syndrome -- Neutrophil Activity in Chronic Granulomatous Disease -- Mycobacterial Infections in Primary Immunodeficiency Patients -- Allergy and Autoimmunity: Prevention or Treatment? -- SLE 1, 2, 3…Genetic Dissection of Lupus -- Network of Myeloid and Plasmacytoid Dendritic Cells in Atopic Dermatitis -- Peptide-Based Therapy in Lupus: Promising Data -- Reduced Number and Function of CD4+ CD25 high FoxP3 + Regulatory T Cells in Patients with Systemic Lupus Erythematosus -- Tumor Immunity in New Dimensions -- Role of Altered Expression of HLA Class I Molecules in Cancer Progression -- Intrathymic Selection: New Insight into Tumor Immunology -- Crosstalk Between Apoptosis and Antioxidants in Melanoma Vasculogenic Mimicry -- Immunological Role of Dendritic Cells in Cervical Cancer -- Sensitizing Tumor Cells to Immune-Mediated Cytotoxicity -- Inhibition of Dendritic Cell Generation and Function by Serum from Prostate Cancer Patients: Correlation with Serum-Free PSA -- Immunomodulators -- Alarmins Initiate Host Defense -- Gangliosides as Immunomodulators -- Functional Changes of Macrophages Induced by Dimeric Glycosaminylmuramyl Pentapeptide -- New Insights in Immune Regulation -- Myeloid-Derived Suppressor Cells -- The Lytic NK Cell Immunological Synapse and Sequential Steps in Its Formation -- Infective, Neoplastic, and Homeostatic Sequelae of the Loss of Perforin Function in Humans -- Natural Killer T (NKT) Cell Subsets in Chlamydial Infections -- Memory T Cells in Allograft Rejection -- Differences in Dendritic Cell Activation and Distribution After Intravenous, Intraperitoneal, and Subcutaneous Injection of Lymphoma Cells in Mice -- Role of IL-1-Mediated Inflammation in Tumor Angiogenesis -- News in Immunodiagnostics and Immunomonitoring -- New Approaches for Monitoring CTL Activity in Clinical Trials -- Serum Levels of Soluble HLA and IL-2R Molecules in Patients with Urogenital Chlamydia Infection -- Evaluation of Suspected Immunodeficiency -- Frequently Ill Children -- Evaluation of Bactericidal Activity of Human Biological Fluids by Flow Cytofluorimetry -- Immunotherapy and Vaccines -- Rational Development of Antigen-Specific Therapies for Type 1 Diabetes -- Interleukin-7 Immunotherapy -- Transmembrane Interactions as Immunotherapeutic Targets: Lessons from Viral Pathogenesis -- Tumor Cell Vaccines -- T Cell Tolerance to Tumors and Cancer Immunotherapy -- Herpes Simplex Virus: Treatment with Antimicrobial Peptides -- Vaccine Containing Natural TLR Ligands Protects from Salmonella typhimurium Infection in Mice and Acute Respiratory Infections in Children -- Lymphocyte Subpopulations in Melanoma Patients Treated with Dendritic Cell Vaccines -- Cell Technologies in Immunotherapy of Cancer -- Therapeutic Potential of Cannabinoid-Based Drugs -- Micro- and Nanoparticle-Based Vaccines for Hepatitis B -- Mast Cells, T Cells, and Inhibition by Luteolin: Implications for the Pathogenesis and Treatment of Multiple Sclerosis.
520 _aThe goal of the International Immune-Mediated Diseases: From Theory to Therapy (IMD) Congress is to bring the best world immunologists and clinicians to Moscow to participate in plenary sessions, symposia and educational workshops designed to expose basic and clinical immunologist as well as practicing clinicians to the newest developments in the field. First IMD Congress consisted of 8 Plenary Sessions, 40 Symposia and 25 Workshops. The meeting attracted almost 2000 participants and speakers from 15 countries. After this great success of the First IMD Congress, the Organizing Committee decided to convene the meeting every other year and the Second International IMD Congress was planned for September 2007. Special attention will be given to innovative therapeutic modalities, allergy and asthma, immunodeficiency, tumor and transplant immunology, immunotherapy and vaccines, HIV and infectious diseases, autoimmune diseases, inflammation, immunomonitoring and immunodiagnostics. This volume includes contributions from the speakers of the Second IMD Congress (September 10-15, 2007; Moscow, Russia) who are eager to share some of the academic and clinical enthusiasm that defines the IMD meetings.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aSmolkin, Yuri S.
_eeditor.
_9305071
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9780387720043
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-72005-0
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c280251
_d280251